Evidence map›Paper›PMID 39164528›Full record

ArticleMolecular psychiatry2025

Targeting high-affinity nicotinic receptors protects against the functional consequences of β-amyloid in mouse hippocampus.

Marie H Sabec, Quentin R Savage, John L Wood, Uwe Maskos

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Marie H SabecInstitut Pasteur, Université Paris Cité, CNRS UMR 3571, Integrative Neurobiology of Cholinergic Systems, 75015, Paris, France. marie.sabec@bristol.ac.uk.ORCID 0000-0002-3109-4762
Quentin R SavageDepartment of Chemistry and Biochemistry, Baylor University, Waco, TX, 76798, USA.
John L WoodDepartment of Chemistry and Biochemistry, Baylor University, Waco, TX, 76798, USA.
Uwe MaskosInstitut Pasteur, Université Paris Cité, CNRS UMR 3571, Integrative Neurobiology of Cholinergic Systems, 75015, Paris, France. uwe.maskos@pasteur.fr.ORCID 0000-0002-2029-1437

Funding

GROWTH FACTORS AND PANCREATIC CANCERK11CA001309 · NCI · VANDERBILT UNIVERSITY · PI BEAUCHAMP, ROBERT D. · 1987 to 1991
–
Cancer Prevention and Research Institute of Texas (Cancer Prevention Research Institute of Texas) CPRIT, R1309U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) CHE-1764240Welch Foundation Chair, AA-006
6 · The paper itself

Abstract

The accumulation of β-amyloid oligomers is a hallmark of Alzheimer's disease, inducing neural and network dysfunction in the early stages of pathology. The hippocampus is affected early in the pathogenesis of AD, however the impact of soluble β-amyloid on the dentate gyrus (DG) subregion of the hippocampus and its interaction with nicotinic acetylcholine receptors (nAChRs) within this region are not known. Using a localized model of over-expression, we show that β-amyloid induces early-onset neuronal hyperactivity and hippocampal-dependent memory deficits in mice. Further, we find the DG region to be under potent and sub-type specific nicotinic control in both healthy and pathophysiological conditions, with targeted receptor inhibition leading to a mnemonic rescue against localized amyloidosis. We show that while neurogenesis and synaptic functions are not severely affected in our model, reducing β2-containing nAChR function is associated with the promotion of young adult-born neurons within the pathological network, suggesting a possible protective mechanism. Our data thus reveal the DG network level changes which occur in the early-stages of β-amyloid accumulation and highlight the downstream consequences of targeted nicotinic neuromodulation.

Indexed as

Amyloid beta-PeptidesHippocampusReceptors, NicotinicAlzheimer DiseaseAnimalsDentate GyrusDisease Models, AnimalMaleMemory DisordersMiceMice, Inbred C57BLMice, TransgenicNeurogenesisNeuronsAmyloid beta-PeptidesReceptors, Nicotinic

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.